Navigation Links
ADVENTRX Announces Consolidation of Clinical and Management Positions
Date:1/30/2008

Company's web site at http://www.adventrx.com.

Forward Looking Statement

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors that, if they do not materialize or prove to be accurate, could cause ADVENTRX's results to differ materially from historical results or those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the risk that preclinical and clinical results are not indicative of the success of subsequent clinical trials and that products will not perform as preclinical or clinical data suggests or as otherwise anticipated; the results of pending clinical trials for ADVENTRX's product candidates; the FDA's views on the appropriateness of seeking marketing approval of certain of ADVENTRX's product candidates under Section 505(b)(2); difficulties or delays in developing, testing, manufacturing and marketing and obtaining regulatory approval for ADVENTRX's product candidates, including receiving necessary regulatory approvals for clinical trials of ANX-514; the potential for regulatory authorities to require additional preclinical work or other clinical requirements to support regulatory filings; patent and non-patent exclusivity covering ADVENTRX's Section 505(b)(2) product candidates; the risk that ADVENTRX will be unable to raise sufficient capital to fund the projects necessary to meet its anticipated or stated goals and milestones; and other risks and uncertainties more fully described in ADVENTRX's press releases and periodic filings with the Securities and Exchange Commission. ADVENTRX's public filings with the Securities and Exchange Commission are available at http://www.sec.gov.

You are cautioned not to place u
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. ADVENTRX Pharmaceuticals to Present at the 20th Annual Bear Stearns Healthcare Conference
4. ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA
5. ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners Fifth Annual Growth Conference
6. ADVENTRX Pharmaceuticals to Present at the 2007 UBS Global Life Sciences Conference
7. ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference
8. ADVENTRX Pharmaceuticals to Present at the 2007 BIOInvestor Forum
9. ADVENTRX Appoints Vice President of Commercialization
10. ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... and VANCOUVER, British Columbia ... ("InMed") (CSE: IN; OTCQB: IMLFF), a clinical stage ... based therapies, today announced that Craig Schneider ... overview during a live webcast at VirtualInvestorConferences.com. ... LINK:   http://VirtualInvestorConferences.com > click the red ...
(Date:3/2/2015)... Editor Note: For more information ... Moments ago, Analysts Review released new research updates concerning ... SSH ), Synergetics USA ... ELOS ), Spectranetics (NASDAQ: SPNC ), and Thoratec ... unified platform for investors, to hear about what matters - ...
(Date:3/2/2015)... Sterlitech is proud to debut its multi-line, fully ... AMTA Membrane Technology Conference in Orlando. This new ... engineering and customer feedback, which has resulted in a ... across an array of disciplines. It is designed ... of researchers and engineers alike and is ideal for ...
(Date:3/1/2015)... Market Publishers Ltd and DataGroup ... research promotion on Internet. MarketPublishers.com is now authorised ... by DataGroup Booksellers. , Natalie Aster, Assistant Manager ... on the recent partnership agreement as follows: “We ... team of publishers. Since 1974, the company has ...
Breaking Biology Technology:InMed Pharmaceuticals to Present Investor Webcast March 5 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 3Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 4Sterlitech Displays Complete CF042 Membrane Test System 2Market Publishers Ltd and DataGroup Booksellers Sign Partnership Agreement 2Market Publishers Ltd and DataGroup Booksellers Sign Partnership Agreement 3
... , , , ... ), a biopharmaceutical company dedicated to improving patient care by developing novel ... and program highlights for the second quarter ended June 30, 2009. ... structure and Phase II protocol allowance from the FDA, we are well ...
... ... ... 30, 2009 -- IntertechPira has teamed up with Carbonfund.org to create a zero-carbon event. ... offsetting those emissions to make the event carbon neutral by supporting energy efficiency, renewable ...
... As ... ... as other commercial real estate sectors struggle, investors continue to pour hundreds of millions ... new debt and $30 million in new equity from Prudential Real Estate Investors (PREI), ...
Cached Biology Technology:Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 2Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 3Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 4Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 5Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 6Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 7Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 8Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 9Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 10Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 11Biopolymers Symposium 2009 Teams with Carbonfund.org to Create a Zero-Carbon Event 2Millions Flowing into Medical Real Estate 2Millions Flowing into Medical Real Estate 3
(Date:2/19/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/kx9zp8/military ) ... Electro-Optical / Infrared Systems Market by Type, by ... to 2020" report to their offering. ... expected to reach $16.35 billion by 2020, to ... report segments the military electro-optical/infrared systems market on ...
(Date:2/12/2015)... 2015   MedNet Solutions , a global ... management systems, has recently bolstered its ... iMedNet as the eClinical solution ... healthcare consultants.  Building on the Program,s existing benefits ... numerous co-marketing opportunities), MedNet,s new and improved program ...
(Date:2/10/2015)... -- Alere Inc. (NYSE: ALR), a global leader in ... quarter ended December 31, 2014. Namal ... said, "We made substantial progress in the fourth ... in rapid diagnostics and delivering against our financial ... early January enabled us to substantially reduce our ...
Breaking Biology News(10 mins):Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33
... came from other planets. So concludes a major scientific article which ... Cosmology.com For thousands ... life. Surprisingly, most scientists and the Catholic Church are of the ... "organic soup." In the Judeo-Christian Bible, the ...
... Dental and tissue engineering researchers at Tufts University School of ... at Tufts have harnessed the pluripotency of human embryonic stem ... skin and the oral mucosa (the moist tissue that lines ... online in advance of print in Tissue Engineering Part ...
... scientists at Iowa State University,s Plant Sciences Institute has ... in plant genes much more efficient, practical and safe. ... associate scientist, and Jeffery Townsend, an assistant scientist, and ... have a huge impact on plant genetic work in ...
Cached Biology News:Life on Earth came from other planets 2Life on Earth came from other planets 3Life on Earth came from other planets 4Skin-like tissue developed from human embryonic stem cells 2Iowa State University researchers develop process for 'surgical' genetic changes 2Iowa State University researchers develop process for 'surgical' genetic changes 3
... In virtually every research laboratory, the ... of information accurately, inexpensively and in real ... compact lab analysis system includes the Luminex ... It utilizes xMAP technology which enables you ...
... Luminex 100 IS System is a compact analysis ... integrates lasers, optics, fluidics, a controller, advanced digital ... powerful, compact lab analysis system includes the Luminex ... it has a DMF file at the FDA, ...
... of amino acids and peptides produced ... It is recommended for laboratory media ... in antibiotics, toxins and enzyme productions. ... pH6.8 0.5 at 25 C, 2% ...
... Highly nutritious peptone, used ... production of bacterial toxins, ... of bacteria with high ... Haemophilus, Neisseria, Pasteurella, Salmonella ...
Biology Products: